Bio-Gene Technology Limited (ASX:BGT)

Australia flag Australia · Delayed Price · Currency is AUD
0.0170
0.00 (0.00%)
Jul 15, 2026, 9:59 AM AEST
Market Cap6.56M -1.2%
Revenue (ttm)n/a
Net Income-2.52M
EPS-0.01
Shares Out 386.08M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume409
Open0.0170
Previous Close0.0170
Day's Range0.0170 - 0.0170
52-Week Range0.0160 - 0.0610
Beta0.76
Analystsn/a
Price Targetn/a
Earnings DateAug 21, 2026

About Bio-Gene Technology

Bio-Gene Technology Limited, an agtech development company, engages in the development and commercialization of naturally derived insecticide products in Australia and internationally. Its products include Flavocide, a synthetically produced nature-identical compound; and Qcide, a natural plant-derived oil with high levels of tasmanone. The company has a research collaboration agreement with James Cook University for experiments demonstrating the value of pre-conditioning biomass prior to distillation; Cesar for assessing the insecticidal activ... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1995
Country Australia
Stock Exchange Australian Securities Exchange
Ticker Symbol BGT
Full Company Profile

Financial Performance

Financial Statements